Word

ORJEMSA

Status

Pending

Status Code

681

Status Date

Thursday, April 18, 2024

Serial Number

97591746

Mark Type

4

Filing Date

Wednesday, September 14, 2022

Published for Opposition

Tuesday, May 21, 2024

Trademark Owner History

Day One Biopharmaceuticals, Inc.

Classifications

5 Pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders; targeted pharmaceutical preparations for use in cancer prevention and treatment; pharmaceutical and veterinary preparations for the delivery of compounds to the body for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders

44 Medical information services; healthcare services; healthcare services, namely, providing cancer treatment information to physicians, health care professionals, and patients; medical information services, namely, providing information regarding viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system diseases and disorders

Trademark Events

Mar 10, 2023

Non-Final Action E-Mailed

Sep 17, 2022

New Application Entered

Sep 29, 2022

New Application Office Supplied Data Entered

Mar 7, 2023

Assigned To Examiner

Mar 10, 2023

Non-Final Action Written

Mar 10, 2023

Notification Of Non-Final Action E-Mailed

Jun 6, 2023

Application Extension To Response Period - Received

Jun 6, 2023

Application Extension Granted/Receipt Provided

Sep 11, 2023

Teas Response To Office Action Received

Sep 11, 2023

Correspondence Received In Law Office

Sep 12, 2023

Teas/Email Correspondence Entered

Oct 10, 2023

Final Refusal Written

Oct 10, 2023

Final Refusal E-Mailed

Oct 10, 2023

Notification Of Final Refusal Emailed

Apr 4, 2024

Correspondence Received In Law Office

Apr 4, 2024

Teas Request For Reconsideration Received

Apr 5, 2024

Teas/Email Correspondence Entered

Apr 18, 2024

Approved For Pub - Principal Register

May 1, 2024

Notification Of Notice Of Publication E-Mailed

Jan 2, 2024

Application Extension Granted/Receipt Provided

Jan 2, 2024

Application Extension To Response Period - Received